Meet the Current ResearchersSee the scientists helping to make a difference with our Research Awards Nationwide, which gives a snapshot of the research we support.
Kevin Harrod, Ph.D.
University of Alabama at Birmingham
Novel SARS-CoV-2 antivirals targeting viral encoded ion channels
Aaron N. Hata, M.D., Ph.D.
Massachusetts General Hospital
Exploiting potent anti-viral immunity against lung cancer through antigenic reprograming
Jason Hong, M.D.
University of California, Los Angeles
Understanding Pulmonary Arterial Hypertension and Predicting Drugs at Single-cell Resolution
Terri Hough, M.D., MSc
Oregon Health & Science University
Recovery after COVID-19 Hospitalization
Lu Huang, Ph.D.
University of Arkansas for Medical Sciences
Targeting Trained Immunity to Develop Novel TB Vaccine
Elizabeth A. Jacobsen, Ph.D.
Mayo Clinic Arizona
Why are Eosinophils Resistant to Steroid Treatment for Severe Asthma?
Dan Jane-wit, M.D., Ph.D.
The Role of ZFYVE21 in COVID-19 Respiratory Complications
Lingtao Jin, Ph.D.
University of Florida
Targeting Protein to Overcome Immunotherapy Resistance in Small Cell Lung Cancer
Nikhil Joshi, Ph.D.
Yale University School of Medicine
Investigating the function of tumor-specific T cells in non-small cell lung
Nada Y. Kalaany, Ph.D.
Boston Children’s Hospital
Identifying metabolic alterations in lung cancer-associated cachexia
Edy Kim, M.D.
Brigham and Women’s Hospital
Seeking Targeted Treatments for Unclassifiable Lung Fibrosis
Ji Yeon Kim, Ph.D.
University of Illinois
Shedding Light on Link Between Mutations and Metabolism in Lung Cancer
Chi Li, Ph.D.
University of Louisville Research Foundation, Inc.
Inhibiting Lung Adenocarcinoma Growth by Inducing Apoptosis Independent of Bcl-2 Proteins
Bo Liang, Ph.D.
Viral Polymerases for RSV and SARS-CoV-2 Could be Key for Prevention and Treatment
Weiwen Long, Ph.D.
Wright State University
Potential Therapeutic Target for Lung Adenocarcinoma with KRAS Mutations
Camila Lopes-Ramos, Ph.D.
Sex and Gender Differences in Lung Adenocarcinoma
Seyed Javad M. Moghaddam, M.D.
University of Texas M.D. Anderson Cancer Center
Developing Immuno-Prevention and Treatment Modalities for KRAS Mutant Lung Cancer
Hyung-Geun Moon, Ph.D.
University of Illinois at Chicago
CSF1-CSF1R pathway for allergen sensitization
Sharon Morley, M.D.,Ph.D.
Washington University in St. Louis
COVID-19 infection, NLRP3 inflammasome activation and therapeutic trials to treat ARDS in a mouse model
Jarrod Mousa, Ph.D.
University of Georgia
Using Monoclonal Antibodies to Protect Against Pneumococcal Pneumonia
Somashekarappa Gowda Nanjappa, Ph.D., D.V.M.
University of Illinois at Urbana-Champaign
Immunity against pulmonary fungal infections
Jac Alexander Nickoloff, Ph.D.
Colorado State University
Targeting Lethal DNA Damage to Lung Cancer Genome Alterations
Rebecca C. Obeng, M.D., Ph.D., M.P.H.
Helping Immune Cells Infiltrate Lung Tumors
Andrea A. Pappalardo, M.D.
University of Illinois
How Do Schools Deal With Access to the Asthma Medication Albuterol?
Alexander Pertsemlidis, Ph.D.
University of Texas Health Sciences Center at San Antonio
MicroRNAs May Help Control Cancer Spread
Irina Petrache, M.D.
National Jewish Health
Novel risk factors for severe COVID-19 lung disease
Amanda Poholek, Ph.D.
University of Pittsburgh
Learning Protein’s Role in Allergic Asthma Could Lead to New Treatments
Kurt Prins, M.D., Ph.D.
University of Minnesota
Treating Right Heart Dysfunction to Improve Outcomes in PAH
Zhaoxia (Julia) Qu, Ph.D.
University of Southern California
Turning Myeloid Immune Cells from Pro-Tumor to Anti-Tumor in Lung Cancer
Joseph Edward Qualls, Ph.D.
Children's Hospital Medical Center
Lactate metabolism and host defense against Mycobacterium tuberculosis